PF-Atlas › Clinical Trials › NCT05914727
Biomarkers Of Lung InVolvement In ASMD
eNose · Not specified
Registry ID
NCT05914727
Phase
Not specified
Status
Unknown
Drug / intervention
eNose
Sponsor
Eline C. B. Eskes
Start
2022-12-05
Enrollment
68
Locations
1
About this trial
The goal of this study is to characterize ASMD patients' breath profile, exhaled breath and condensate as compared to healthy controls to identify specific volatile and non-volatile compounds that reflect inflammatory processes, fibrotic processes or sphingolipid accumulation in the lungs. Participants will be provided exhaled breath samples in three ways (breath profile, volatile compounds and condensate). ASMD patients will be compared to age- and sex-matched healthy controls.
Explore related
Medical disclaimer. This page summarizes public trial data for NCT05914727 for information only. It is not medical advice, an endorsement, or an offer to enroll. Confirm details on ClinicalTrials.gov and with a qualified physician.